Fresenius SE KGaAXSWX:FRE 71 14-Day RSI is 65.63 as of Jun. 27, 2026. GuruFocus rates XSWX:FRE with a GF Score™ of 71/100 and a GF Value™ of CHF33.18 (Fairly Valued). The stock has 5 warning signs investors should review. Among 703 Healthcare Providers & Services companies, Fresenius SE KGaA ranks worse than 82.79% on this metric.
The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100. Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30.
The industry rank for Fresenius SE KGaA's 14-Day RSI or its related term are showing as below:
XSWX:FRE's 14-Day RSI is ranked worse than 82.79% of 703
companies
in the Healthcare Providers & Services industry
Industry Median: 47.06
vs XSWX:FRE: 65.63
Fresenius SE KGaA (XSWX:FRE) 14-Day RSI Explanation
The Relative Strength Index (RSI), developed by J. Welles Wilder in his book “New Concepts in Technical Trading Systems.”, is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100.
Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A RSI surpasses the 30 level indicates a bullish sign, when it slides below 70 level, it’s a bearish sign. This level can be adjusted depending on the security’s pattern and the market’s underlying trend. In an uptrend or bullish market, the RSI might range within a higher interval, investors could set the support level higher. If a downtrend or bearish market occurs, investors may need to lower the resistance level.
RSI can also be used in trading techniques to indicate the trading signal, such as Divergences and Swing Rejections.
Fresenius SE KGaA 14-Day RSI Related Terms
XSWX:FRE vs HCA, THC, DVA: 14-Day RSI Comparison
For the Medical Care Facilities subindustry, Fresenius SE KGaA's 14-Day RSI, along with its competitors' market caps and 14-Day RSI data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Fresenius SE KGaA 14-Day RSI vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Fresenius SE KGaA's 14-Day RSI distribution charts can be found below:
* The bar in red indicates where Fresenius SE KGaA's 14-Day RSI falls into.
Fresenius SE KGaA (XSWX:FRE) 14-Day RSI Calculation
The formula for calculating RSI is:
RSI
=
100
–
[ 100
/
( 1 + Average Gain
/
Average Loss )]
* Note that the formula uses a positive value for the average loss.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Fresenius SE KGaA (XSWX:FRE) has a 14-Day RSI of 65.63 as of Jun. 27, 2026. Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. View historical data on Fresenius SE KGaA and its competitors. According to the industry distribution chart, Fresenius SE KGaA ranks #582 out of 703 companies in the Healthcare Providers & Services industry, placing it in the top 82.8%.
Is Fresenius SE KGaA's 14-Day RSI too high?
Fresenius SE KGaA's current 14-Day RSI is 65.63. The Healthcare Providers & Services industry median 14-Day RSI is 47.06. Fresenius SE KGaA's value of 65.63 is 39.5% above this industry median. Based on the distribution chart, Fresenius SE KGaA ranks #582 out of 703 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Fresenius SE KGaA has a GF Score™ of 71/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Fresenius SE KGaA's 14-Day RSI compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Fresenius SE KGaA ranks #582 out of 703 companies for 14-Day RSI. This places Fresenius SE KGaA in the lower half of its industry. The industry median 14-Day RSI is 47.06. Fresenius SE KGaA's value of 65.63 is 39.5% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 14-Day RSI for a Healthcare Providers & Services company?
The median 14-Day RSI among Healthcare Providers & Services companies is 47.06, based on 703 companies in the industry. Companies in the top quartile (top 25%) have a 14-Day RSI significantly above this median, while those in the bottom quartile fall well below. However, 14-Day RSI should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Fresenius SE KGaA's current 14-Day RSI of 65.63 is 39.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 14-Day RSI mean?
A high 14-Day RSI can signal that a stock is expensive relative to its fundamentals. Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. View historical data on Fresenius SE KGaA and its competitors. For the Healthcare Providers & Services industry, the median 14-Day RSI is 47.06 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Fresenius SE KGaA's current 14-Day RSI is 65.63. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Fresenius SE KGaA stock overvalued right now?
Based on GuruFocus' analysis, Fresenius SE KGaA (XSWX:FRE) is currently considered Fairly Valued. The stock's GF Value™ is CHF33.18, compared to a current price of CHF36.15 — trading 9% above its estimated fair value. The current 14-Day RSI is 65.63 and 39.5% above the Healthcare Providers & Services industry median of 47.06. Fresenius SE KGaA's overall GF Score™ is 71/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 14-Day RSI calculated?
14-Day RSI is calculated from a company's financial statements. For Fresenius SE KGaA (XSWX:FRE), the current 14-Day RSI is 65.63 as of Jun. 27, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Fresenius SE KGaA (XSWX:FRE) Overvalued in 2026?
Based on GuruFocus' analysis, Fresenius SE KGaA stock appears to be overvalued.
The current stock price of CHF36.15 is trading 9% above its estimated GF Value™ of CHF33.18.
GuruFocus considers Fresenius SE KGaA to be Fairly Valued.
Key valuation signals for XSWX:FRE:
14-Day RSI: 65.63
GF Value™: CHF33.18 vs. price of CHF36.15 (9% above fair value)
Industry Position: 39.5% above the Healthcare Providers & Services median (#582 of 703)
No single metric tells the full story. See the XSWX:FRE stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Fresenius is a healthcare holding company based in Germany. The company owns a minority stake in dialysis service provider and equipment manufacturer Fresenius Medical Care. The Kabi segment manufactures intravenous drugs, nutrition products, infusion and transfusion therapies, and related pumps. The Helios segment operates private hospitals primarily in Germany and Spain.
71GF Score
Get the complete analysis for XSWX:FRE
14-Day RSI is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XSWX:FRE has been successfully added to your 